Cherry Tree Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-800
Closed -$43.2K 587
2025
Q4
$43.2K Sell
800
-213
-21% -$10.2K 0.01% 280
2025
Q3
$45.7K Hold
1,013
0.01% 265
2025
Q2
$46.9K Hold
1,013
0.01% 261
2025
Q1
$61.8K Hold
1,013
0.01% 245
2024
Q4
$57.3K Hold
1,013
0.01% 246
2024
Q3
$52.4K Hold
1,013
0.01% 254
2024
Q2
$42.1K Hold
1,013
0.01% 262
2024
Q1
$54.9K Hold
1,013
0.01% 243
2023
Q4
$52K Sell
1,013
-29
-3% -$1.52K 0.01% 239
2023
Q3
$60.5K Hold
1,042
0.02% 218
2023
Q2
$66.6K Buy
+1,042
New +$69.9K 0.02% 213

Other funds holding BMY

Cherry Tree Wealth Management's BMY Position: Q1 2026 in Review

Cherry Tree Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 800 shares — an estimated $43.2K sold.

Cherry Tree Wealth Management first reported a position in BMY in Q2 2023 and held it in 11 quarters. The position peaked at $66.6K in Q2 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Cherry Tree Wealth Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Cherry Tree Wealth Management sold 800 Bristol-Myers Squibb shares in Q1 2026, an estimated $43.2K.
  • Cherry Tree Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2023 and held it in 11 quarters.
  • Cherry Tree Wealth Management's Bristol-Myers Squibb position peaked at $66.6K in Q2 2023.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Cherry Tree Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.